2025-05-22 – Press Releases – www.prnewswire.com
CHENGDU, China, May 22, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that a new indication application (the “Application”) for the Company’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab…
